TrialInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2024

A phase II, multicenter, open-label study of abemaciclib and letrozole in patients with estrogen receptor-positive rare ovarian cancer: ALEPRO trial.

Tine Ottenbourgs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.